Cancers (Apr 2024)

Application of PET/MRI in Gynecologic Malignancies

  • Sheida Ebrahimi,
  • Elin Lundström,
  • Summer J. Batasin,
  • Elisabeth Hedlund,
  • Karin Stålberg,
  • Eric C. Ehman,
  • Vipul R. Sheth,
  • Negaur Iranpour,
  • Stephane Loubrie,
  • Alexandra Schlein,
  • Rebecca Rakow-Penner

DOI
https://doi.org/10.3390/cancers16081478
Journal volume & issue
Vol. 16, no. 8
p. 1478

Abstract

Read online

The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.

Keywords